TrackPaw Scientific AB

Based in Sweden, TrackPaw Scientific AB develops advanced digital monitoring solutions for preclinical research, enhancing animal welfare through innovative behavioral analysis technologies. TrackPaw Scientific AB, founded in 2022 in Lund, Sweden, specializes in digital monitoring solutions aimed at improving the welfare and behavioral analysis of research animals. The company raised EUR 2. 3 million in Seed funding on August 5, 2025, co-led by investors Fahraeus Startup and Growth and Industrifonden, with participation from returning investor I Love Lund.

TrackPaw has completed 3 deals to date, solidifying its presence in the market. Trackpaw Scientific specializes in advanced digital monitoring solutions for preclinical research, focusing on the welfare and behavioral analysis of research animals. The core product offering includes a 24/7 digital monitoring system that tracks weight, activity, and behavioral patterns, significantly reducing the need for stressful manual interventions. This technology enables researchers to gain insights into vital physiological parameters that would otherwise remain unnoticed, thus ensuring data integrity and the well-being of the animals.

The built-in alarm function allows for immediate action in response to unforeseen activities, ensuring that researchers can prevent data loss due to outlier incidents. Trackpaw's products are primarily utilized by research institutions and pharmaceutical companies in North America and Europe, with a commitment to enhancing animal welfare in alignment with the 3Rs (Replacement, Reduction, Refinement) principles. Trackpaw Scientific operates on a subscription-based revenue model, providing its monitoring solutions directly to clients in the research and pharmaceutical sectors. Clients typically engage in annual contracts for access to the monitoring system, which may include additional services such as technical support and software updates.

The pricing structure is designed to cater to various research needs, with options for tailored solutions based on the scale and complexity of the research facilities. The company's flagship monitoring system serves as a critical tool in drug development and animal welfare assessments, solidifying its position in the market. By establishing direct relationships with research institutions and pharmaceutical companies, Trackpaw ensures a steady revenue stream through ongoing subscriptions, driving continuous innovation in their product offerings. In August 2025, TrackPaw Scientific AB raised EUR 2.

3 million in Seed funding to support the commercial launch of its products. The company aims to expand its market presence by introducing new monitoring technologies tailored for various research needs and plans to penetrate additional regions within Europe and North America by 2026.